2010 annual financial data
BioCryst Pharmaceuticals 2010 Operating margin
BioCryst Pharmaceuticals 2010 operating margin with verified reported values.
Direct answer
Operating margin was -52.34%.
Operating income was -33,237,000 USD and net income was -32,733,000 USD.
Operating cash flow was -28,554,221 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 63,501,000 USD
- Operating income
- -33,237,000 USD
- Net income
- -32,733,000 USD
- Operating cash flow
- -28,554,221 USD